We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+10.21%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$232M
AUM Growth
-$37.3M
Cap. Flow
-$107M
Cap. Flow %
-45.9%
Top 10 Hldgs %
59.19%
Holding
75
New
16
Increased
5
Reduced
5
Closed
41

Top Buys

Rank Stock Value
1
GTLS
Chart Industries
GTLS
+$16.1M
2
STZ icon
Constellation Brands
STZ
+$9.57M
3
ALIT icon
Alight
ALIT
+$8.16M
4
LAUR icon
Laureate Education
LAUR
+$7.54M
5
GTLS.PRB
Chart Industries 6.75% Series B Preferred Stock
GTLS.PRB
+$7.4M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$83.5M
2
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$31.6M
3
GOSS icon
Gossamer Bio
GOSS
+$8.31M
4
PM icon
Philip Morris
PM
+$5.4M
5
CRBG icon
Corebridge Financial
CRBG
+$4.92M

Sector Composition

Rank Sector Weight
1 Healthcare 19.43%
2 Industrials 8.29%
3 Consumer Staples 6.88%
4 Technology 4.4%
5 Energy 2.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VTI icon
1
Vanguard Morningstar Total Stock Market ETF
VTI
$646B
$59.3M 25.51%
310,000
-164,000
-35% -$31.6M
GTLS
2
DELISTED
Chart Industries
GTLS
$11.5M 4.96%
+100,000
New +$16.1M
CMPX icon
3
Compass Therapeutics
CMPX
$349M
$11.2M 4.83%
2,230,441
+1,000,000
+81% +$3.99M
STZ icon
4
Constellation Brands
STZ
$22.5B
$9.27M 3.99%
+40,000
New +$9.57M
ALIT icon
5
Alight
ALIT
$534M
$8.19M 3.52%
+48,970
New +$8.16M
GTLS.PRB
6
DELISTED
Chart Industries 6.75% Series B Preferred Stock
GTLS.PRB
$7.6M 3.27%
+150,000
New +$7.4M
COR icon
7
Cencora
COR
$62B
$7.46M 3.21%
+45,000
New +$7.11M
LAUR icon
8
Laureate Education
LAUR
$5.38B
$6.72M 2.89%
+698,304
New +$7.54M
QQQ icon
9
Invesco QQQ Trust
QQQ
$436B
$6.66M 2.87%
25,000
-302,000
-92% -$83.5M
ASPN icon
10
Aspen Aerogels
ASPN
$339M
$5.95M 2.56%
+505,000
New +$5.77M
ANTX icon
11
AN2 Therapeutics
ANTX
$181M
$4.29M 1.85%
450,000
+216,670
+93% +$2.9M
ROIV icon
12
Roivant Sciences
ROIV
$23.6B
$3.76M 1.62%
+470,000
New +$2.61M
NFE icon
13
New Fortress Energy
NFE
$92.9M
$3.72M 1.6%
+87,700
New +$4.24M
PLRX icon
14
Pliant Therapeutics
PLRX
$65M
$2.9M 1.25%
150,000
+50,000
+50% +$1.05M
BHVN icon
15
Biohaven
BHVN
$2.02B
$2.78M 1.19%
200,000
-209,200
-51% -$2.95M
RAIN
16
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$2.51M 1.08%
+314,171
New +$1.97M
SLGC
17
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$2.51M 1.08%
1,000,000
– –
CRGY icon
18
Crescent Energy
CRGY
$3.65B
$2.1M 0.9%
175,000
+50,000
+40% +$688K
INDI icon
19
indie Semiconductor
INDI
$636M
$2.04M 0.88%
+350,000
New +$2.58M
BLU
20
DELISTED
BELLUS Health Inc.
BLU
$2.01M 0.87%
245,000
+215,000
+717% +$2M
KPTI icon
21
Karyopharm Therapeutics
KPTI
$155M
$1.64M 0.7%
+32,113
New +$2.23M
DYN icon
22
Dyne Therapeutics
DYN
$4.68B
$1.43M 0.62%
123,719
-76,281
-38% -$883K
AURA icon
23
Aura Biosciences
AURA
$725M
$1.38M 0.59%
+131,640
New +$1.68M
TERN
24
DELISTED
Terns Pharmaceuticals
TERN
$1.25M 0.54%
+122,500
New +$815K
TE
25
T1 Energy
TE
$1.04B
$1.08M 0.47%
+125,000
New +$1.57M
1
2 3

Similar funds

EFIC
Eliot Finkel Investment Counsel Beverly Hills, California $184M AUM 33.43% 1-Year Est. Return
SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
AAM
Ameraudi Asset Management New York $184M AUM 15.4% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
KWM
KMT Wealth Management El Segundo, California $184M AUM 17.2% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return

Monashee Investment Management's Q4 2022 Portfolio in Review

As of Q4 2022, Monashee Investment Management held 75 positions worth $232M, down 14% from $270M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Monashee Investment Management withdrew a net $107M in Q4 2022, closing 41 positions and reducing 5 holdings. Its most notable exit was Gossamer Bio, an estimated $8.31M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Industrials and Consumer Staples.

Against the trend, Monashee Investment Management opened a new position in Chart Industries worth $11.5M.

  • Monashee Investment Management's largest Q4 2022 buy was Chart Industries: 100,000 shares worth $11.5M.
  • Monashee Investment Management added most to Compass Therapeutics in Q4 2022, an estimated $3.99M increase.
  • Monashee Investment Management's biggest Q4 2022 reduction was Invesco QQQ Trust, cutting an estimated $83.5M.
  • Monashee Investment Management fully exited Gossamer Bio in Q4 2022, selling an estimated $8.31M.
  • Monashee Investment Management's ten largest holdings make up 59% of its $232M portfolio in Q4 2022.
  • Monashee Investment Management opened 16 new positions and closed 41 in Q4 2022.
  • Monashee Investment Management's portfolio value fell 14% quarter-over-quarter to $232M.

Based on Monashee Investment Management's 13F filing for Q4 2022, filed 9 Feb 2023.